Chronic Kidney Disease Requiring Healthcare Services: A New Approach to Evaluate Epidemiology of Renal Disease

Table 2

Healthcare resources used for the identification of first CKD diagnosis.

Healthcare resources	CKD patients
	= 1,989 (%)
CKD-related hospital discharge diagnoses^*	1,151 (57.9)
Primary diagnosis	258 (13.0)
Secondary diagnosis	867 (43.6)
Procedures	39 (2.0)
CKD-related conditions as indication of use for drug prescriptions	838 (42.1)
Allopurinol	213 (10.7)
Furosemide	94 (4.7)
Polystyrene sulfonate	63 (3.2)
Calcitriol	56 (2.8)
Ramipril	29 (1.5)
Metformin and sulfonamides	28 (1.4)
Acetylsalicylic acid	24 (1.2)
Metformin	22 (1.1)
Electrolytes solutions	19 (1.0)
Glimepiride	16 (0.8)
Ferrous sulfate	12 (0.6)
Torasemide	12 (0.6)
Amlodipine	11 (0.6)
Simvastatin	10 (0.5)
Bisoprolol	9 (0.5)
Nebivolol	9 (0.5)
Losartan	9 (0.5)
Atorvastatin	9 (0.5)
Spironolactone	8 (0.4)
Ramipril plus diuretics	8 (0.4)
Others^**	177 (33.2)

Categories of discharge diagnoses and procedures are not mutually exclusive as in some patients CKD-related discharge diagnosis and procedures may have been registered at the same time.
Other drugs which account for less than 0.4% of first CKD diagnosis identification.